Car-t after stem cell transplantation in b-cell lymphoproliferative disorders: are they really autologous or allogenic cell therapies?

HIGHLIGHTS

  • who: Ariadna Bartoló-Ibars and collaborators from the Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain have published the Article: CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies?, in the Journal: Cancers 2021, 13, 4664. of /2021/
  • what: In this review the authors focus on allo-HSCT and CAR-T treatments and the different sources of T-cells for manufacturing CAR T-cells. In this line, current work is focused . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?